Rezolute, Inc. (RZLT)
$4.61-5.34%Close
BUYRECOVERY · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $444M
- Beta
- 0.61
- P/E (TTM)
- -6.07
- Short % float
- 25.32%
- Days to cover
- 8.9
- SI change
- -0.6%
- 1W
- +6.71%
- 1M
- +8.47%
- vs SPY 1W
- +6.85%
- vs SPY 1M
- +5.96%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RZLT?
- LOPJLB’s latest quantitative signal on Rezolute, Inc. (RZLT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is RZLT in?
- Rezolute, Inc. (RZLT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Rezolute, Inc. (RZLT) do?
- Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for …